← All organizations
Highest phase reached
Phase 4
First clinical trial
Jul 3, 2015Last known activity
Jul 1, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (12 distinct, 7 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (4 own, 0 via acquisition)
Other trials (5 own, 0 via acquisition)
Indications
Recent trials (9)
- NCT06990854CollaboratorN/AJul 1, 2025
- NCT06924762CollaboratorPhase 2/Phase 3Mar 19, 2025
- NCT06643689CollaboratorPhase 2Jan 1, 2025
- NCT06261801Sponsor investigatorN/AFeb 7, 2024
- NCT06261801Lead sponsorN/AFeb 7, 2024
- NCT06077331Overall official - principal investigatorPhase 2Sep 28, 2023
- NCT06077331OfficialPhase 2Sep 28, 2023
- NCT03792542CollaboratorPhase 2Jan 31, 2019
- NCT04202068Overall official - principal investigatorPhase 4Jul 3, 2015
Details
- Last known activity
- Jul 1, 2025